✦ LIBER ✦

Transplantation of allogeneic peripheral blood stem cells after myeloablative treatment of a patient in blastic crisis of chronic myelocytic leukemia

✍ Scribed by Dr. Atsuko Sasaki; Machiko Tsukaguchi; Manabu Hirai; Hidehiro Ohira; Yoshitaka Nakao; Takahisa Yamane; Keunsik Park; Taesung Im; Noriyuki Tatsumi

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 622 KB
Volume: 47
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830470110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as

In vitro and in vivo characterization of

In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation

✍ Toshiro Kurokawa; Karin Fischer; Hartmut Bertz; Stefan Hoegerle; Jürgen Finke; A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 264 KB 👁 1 views

It has been shown that after allogeneic peripheral blood stem cell transplantation (PBSCT), donor T cells can induce potent graft-versus-tumor (GVT) effects in hematologic malignancies and possibly solid tumors such as renal cell carcinoma. Two patients (27 and 30 years old) with metastatic melanoma

Prophylactic growth factor-primed donor

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies

✍ Sang-Kyun Sohn; Jin-Tae Jung; Dong-Hwan Kim; Nan-Young Lee; Kwang-Woon Seo; Yee- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Bone marrow necrosis in a patient with a

Bone marrow necrosis in a patient with acute myeloblastic leukemia during administration of G-CSF and rapid hematologic recovery after allotransplantation of peripheral blood stem cells

✍ Katayama, Yoshio; Deguchi, Seigo; Shinagawa, Katsuji; Teshima, Takanori; Notohar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Allogeneic peripheral blood stem cell transplantation from an HLA-identical sibling was performed for a 38-year-old male with refractory acute myeloblastic leukemia. The patient was conditioned with total body irradiation (TBI) and high-dose cytosine arabinoside (Ara-C). G-CSF (300 µg/body) was star